Ina Liko1,2, Yee Ming Lee2, Danielle L Stutzman2,3,4, Allison B Blackmer2,3,5, Kimberly M Deininger1, Ann M Reynolds5,6, Christina L Aquilante1. 1. Department of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences, Aurora, CO 80045, USA. 2. Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences, Aurora, CO 80045, USA. 3. Department of Pharmacy, Children's Hospital Colorado, Aurora, CO 80045, USA. 4. Pediatric Mental Health Institute, Children's Hospital Colorado, Aurora, CO 80045, USA. 5. Special Care Clinic, Children's Hospital Colorado, Aurora, CO 80045, USA. 6. Department of Pediatrics, University of Colorado School of Medicine & Children's Hospital Colorado, Aurora, CO 80045, USA.
Abstract
Aim: To assess providers' knowledge, attitudes, perceptions, and experiences related to pharmacogenomic (PGx) testing in pediatric patients. Materials & methods: An electronic survey was sent to multidisciplinary healthcare providers at a pediatric hospital. Results: Of 261 respondents, 71.3% were slightly or not at all familiar with PGx, despite 50.2% reporting prior PGx education or training. Most providers, apart from psychiatry, perceived PGx to be at least moderately useful to inform clinical decisions. However, only 26.4% of providers had recent PGx testing experience. Unfamiliarity with PGx and uncertainty about the clinical value of testing were common perceived challenges. Conclusion: Low PGx familiarity among pediatric providers suggests additional education and electronic resources are needed for PGx examples in which data support testing in children.
Aim: To assess providers' knowledge, attitudes, perceptions, and experiences related to pharmacogenomic (PGx) testing in pediatric patients. Materials & methods: An electronic survey was sent to multidisciplinary healthcare providers at a pediatric hospital. Results: Of 261 respondents, 71.3% were slightly or not at all familiar with PGx, despite 50.2% reporting prior PGx education or training. Most providers, apart from psychiatry, perceived PGx to be at least moderately useful to inform clinical decisions. However, only 26.4% of providers had recent PGx testing experience. Unfamiliarity with PGx and uncertainty about the clinical value of testing were common perceived challenges. Conclusion: Low PGx familiarity among pediatric providers suggests additional education and electronic resources are needed for PGx examples in which data support testing in children.
Authors: E J Stanek; C L Sanders; K A Johansen Taber; M Khalid; A Patel; R R Verbrugge; B C Agatep; R E Aubert; R S Epstein; F W Frueh Journal: Clin Pharmacol Ther Date: 2012-01-25 Impact factor: 6.875
Authors: Mary V Relling; Matthias Schwab; Michelle Whirl-Carrillo; Guilherme Suarez-Kurtz; Ching-Hon Pui; Charles M Stein; Ann M Moyer; William E Evans; Teri E Klein; Federico Guillermo Antillon-Klussmann; Kelly E Caudle; Motohiro Kato; Allen E J Yeoh; Kjeld Schmiegelow; Jun J Yang Journal: Clin Pharmacol Ther Date: 2019-01-20 Impact factor: 6.875
Authors: Kimberly M Deininger; Shirley M Tsunoda; Jan D Hirsch; Heather Anderson; Yee Ming Lee; Colleen K McIlvennan; Robert L Page; Jacinda N Tran; Christina L Aquilante Journal: Clin Transplant Date: 2020-08-06 Impact factor: 2.863
Authors: Laura B Ramsey; Lisa B Namerow; Jeffrey R Bishop; J Kevin Hicks; Chad Bousman; Paul E Croarkin; Carol A Mathews; Sara L Van Driest; Jeffrey R Strawn Journal: J Am Acad Child Adolesc Psychiatry Date: 2020-08-26 Impact factor: 13.113
Authors: Kristin W Weitzel; D Max Smith; Amanda R Elsey; Benjamin Q Duong; Benjamin Burkley; Michael Clare-Salzler; Yan Gong; Tara A Higgins; Benjamin Kong; Taimour Langaee; Caitrin W McDonough; Benjamin J Staley; Teresa T Vo; Dyson T Wake; Larisa H Cavallari; Julie A Johnson Journal: Clin Transl Sci Date: 2018-01-19 Impact factor: 4.689
Authors: Christina L Aquilante; David P Kao; Katy E Trinkley; Chen-Tan Lin; Kristy R Crooks; Emily C Hearst; Steven J Hess; Elizabeth L Kudron; Yee Ming Lee; Ina Liko; Jan Lowery; Rasika A Mathias; Andrew A Monte; Nicholas Rafaels; Matthew J Rioth; Emily R Roberts; Matthew Rg Taylor; Connie Williamson; Kathleen C Barnes Journal: Pharmacogenomics Date: 2020-02-20 Impact factor: 2.533
Authors: Charlotte I S Barker; Gabriella Groeneweg; Anke H Maitland-van der Zee; Michael J Rieder; Daniel B Hawcutt; Tim J Hubbard; Jesse J Swen; Bruce C Carleton Journal: Br J Clin Pharmacol Date: 2022-02-07 Impact factor: 3.716
Authors: Pritmohinder S Gill; Feliciano B Yu; Patricia A Porter-Gill; Bobby L Boyanton; Judy C Allen; Jason E Farrar; Aravindhan Veerapandiyan; Parthak Prodhan; Kevin J Bielamowicz; Elizabeth Sellars; Andrew Burrow; Joshua L Kennedy; Jeffery L Clothier; David L Becton; Don Rule; G Bradley Schaefer Journal: J Pers Med Date: 2021-05-11